Introduction
Urinary enzyme activities, especially N-acetyl-β-Dglucosaminidase (NAG), had been shown to be a useful early marker of renal injury in clinical diagnosis. 1, 2 NAG is a lysosomal enzyme of 130 kDa molecular mass, normally excreted in low amounts in urine as a consequence of the normal exocytosis process. 3 The urinary excretion of NAG is increased in subjects exposed to substances toxic for renal tubular cells. Therefore, the urinary excretion of NAG is a relatively simple and fast noninvasive method in the detection and follow-up of renal tubular function. Increased NAG levels in urine are an early indication of renal disease and can serve as a valuable renal monitoring test in disorders such as nephritic syndrome, nephrotoxic drugs, urinary tract infection, heavy metal, poisoning, kidney transplants, vesicoureteral reflux, and diabetes mellitus. 1 Currently, there are several methods of assaying the urinary NAG activity, including colorimetric, 4 fluorometric, 5, 6 and chemiluminescent detections. 7 The colorimetric method is based on highly soluble and stable 4-nitrophenyl-N-acetyl-β-Dglucosaminide or its analogues as substrate. Because low levels of NAG are excreted by normal individuals, the sensitivity of the assay could only be kept at an acceptable level by the addition of large aliquots of the urine samples to the reaction mixtures. Therefore, several fluorogenic and chemiluminogenic substrates have been developed for the NAG assay, such as 4-methylumbelliferyl-N-acetyl-β-D-glucosaminide (4-MU-GlcNAc), 5 fluorescein di(N-acetyl-β-D-glucosaminide) 6 and o-amino-phthalyl hydrazido-N-acetyl-β-D-glucosaminide. 7 Clinical diagnostics is one of the most promising applications for microfluidic lab-on-a-chip technologies. All the benefits of miniaturization, such as reduced sample requirement, reduced reagent consumption, decreased analysis time and automation, are realized in this application. In the field of microfluidic lab-on-a-chip systems, microfluidic devices typically depend upon electrokinetic or traditional pressure methods to move small amounts of fluid around a chip. The centrifugal microfluidic platform, which is also known as the lab-on-a-compact-disc (Lab-CD), has emerged as a unique approach to the development of integrated total analysis systems. The Lab-CD platform was first developed almost 40 years ago. 8 Microfluidic channels and reservoirs are embedded in a CD-like plastic substrate and the CD substrate is spun on a simple electric motor in order to manipulate fluids. Centrifugal pumping for fluid propulsion requires no external interconnects to induce fluid movement. Over the last decade, there has been a dramatically increasing interest in the development and realization of Lab-CD platforms, as described in several reviews. [8] [9] [10] They have been also employed for several biomedical applications, such as assays for hepatic enzyme and choresterol, 11 immunoassay for Hepatitis B virus, 12 α-fetoprotein, 13 carcinoembryonic antigen, 11 interleukin-6, 13, 14 creatine kinase muscle-brain fraction (CK-MB), 11 C-reactive protein, 14 and secretory immunoglobulin A; 15 and DNA hybridization for rapid screening of phenylketonuria. 16 However, the recent trend toward developing microfluidic systems has resulted in more integrated and complicated devices. A simple combination of centrifugal pumping, passive capillary valves, and enzyme assay on a Lab-CD has been developed, 17 but its applications have not expanded to various enzyme assays for clinical chemistry. Therefore, we proposed a simple microfluidic A centrifugal microfluidic platform, which is also known as lab-on-a-compact-disc (Lab-CD), was developed for use as a urinary N-acetyl-β-D-glucosaminidase (NAG) activity assay. In this work, Lab-CD design, centrifugal operations and analytical procedures were established. Automated liquid handling on Lab-CD processes, such as fluid transport, sample metering, mixing, and fluorescence detection are accomplished using a portable Lab-CD system. The linearity of the NAG assay using 4-methylumbelliferyl-N-acetyl-β-D-glucosaminide (4-MU-GlcNAc) was found to be acceptable in the range of 2.5 to 20 U L -1 ; the relative standard deviations for the fluorescence intensity of eight samples (7.5 U L -1 ) was 6.4%. Clinical diagnostics is one of the most promising applications for Lab-CD technologies. All the benefits of miniaturization, such as reduced sample requirement, reduced reagent consumption and automation, are realized in this investigation.
(Received September 5, 2011; Accepted October 27, 2011; Published January 10, 2012) device for the determination of NAG activity in urine samples. The superiority of the present approach is that a whole range of fluidic functions, which include low volume sample measurement, mixing, enzyme reaction and detection, have been accomplished by a simple microfluidic structure and a centrifugal rotation. A Lab-CD assay method that was based on the fluorescence of 4-methylumbelliferone (4-MU) produced by enzymic hydrolysis of 4-methylumbelliferyl substrate (4-MU-GlcNAc) was developed.
Experimental

Lab-CD fabrication
Silicon wafers with a 10-cm diameter were purchased from SUMCO (Tokyo, Japan), SU-8 50 and SU-8 100 were purchased from MicroChem (Newton, MA), 2-acetoxy-1-methoxypropane (SU-8 developer) was from Kanto Chemicals (Tokyo, Japan), buffered hydrogen fluoride solution (BHF110U) was from Daikin Industrials (Osaka, Japan), and poly(dimethylsiloxane) (PDMS) composed of prepolymer and curing agent (Silpot 184 W/C) was from Dow Corning Toray (Tokyo, Japan).
Spin coating of SU-8 on a silicon wafer was performed using a spin coater (MS-A150, MIKASA, Tokyo, Japan). The UV lithography was processed using a mask aligner (MA-10, MIKASA). According to the manufacturer's instructions, the molding process for patterning a silicon wafer with SU-8 was performed by the following steps: cleaning with buffered hydrogen fluoride solution, resist spin, pre-exposure bake, exposure, post-exposure bake, development and hard bake. A PDMS chip was fabricated by cast molding of a 10:1 mixture of PDMS prepolymer and curing agent. The PDMS mixture was degassed and baked at 50 C for more than 2.5 h. The PDMS replica was peeled off from the mold, and further baked (125 C for more than 40 min) to complete the bonding. The dimensions of microchannels and metering chambers were measured by a confocal laser scanning microscope (Optelics C130, Lasertec, Yokohama, Japan). Holes for liquid reservoir and air vent were punched through the PDMS chip using a trephine biopsy tool. Figure 1 shows the geometric design of microfluidic channels and reservoirs. The microchanel dimensions are given in Table 1 . A schematic diagram and picture of a 10-cm Lab-CD with 12 sets of enzyme assay are shown in Fig. 2 . It is composed of a top (cover) and microfluidic plate made of PDMS (ca. 1 mm thickness each); the microfluidic plate is sealed on the bottom with either a PDMS plate (ca. 0.5 mm thickness) or a clear polyethylene terephthalate (PET) film for microplate seal (ca. 0.075 mm thickness, Cat. No. 1-6774-01, AS ONE, Osaka, Japan). In preliminary experiments, a Lab-CD sealed with PET film was used repeatedly after peeling off the PET film, rinsing with water, and baking at 125 C for more than 40 min. On the top plate, sample and reagent introduction ports of 1.5 -2.0 mm diameter were only built for preventing scattering of sample and/or reagent solutions caused by the centrifugal force upon first rotation.
Centrifugal Lab-CD system
The centrifugal analytical instrument was manufactured by Rohm (Kyoto, Japan), and is shown in Fig. 3 . LabVIEW software was used for the instrument operation and control. Fluorescence detection was performed using a fiber-optic fluorescence detector (SELFOC μFLE1000, Nippon Sheet Glass, Tokyo, Japan). In preliminary experiments to establish the operating conditions of Lab-CD, centrifugal rotation was performed using a spin coater (1H-DX2, MIKASA). The fluid flow behaviors of the liquid in the microchannels and reservoirs were observed using a Leica MZ FL III fluorescence stereomicroscope (Leica Microsystems, Wetzlar, Germany) equipped with a CCD camera (VB-7010, Keyence, Osaka, Japan).
Enzyme assay on a Lab-CD platform
4-Methylumbelliferyl-N-acetyl-β-D-glucosaminide (4-MU-GlcNAc) was purchased from Sigma-Aldrich Japan (Tokyo, Japan), β-N-acetylhexosaminidase purified from jack bean was purchased from Seikagaku Biobusiness (Tokyo, Japan), and 4-methylumbelliferone (4-MU) was from Tokyo Kasei (Tokyo, Japan). All other chemicals used were reagent grade or better. A substrate solution containing 100 μM of 4-MU-GlcNAc was prepared by dissolving in 200 mM citrate-phosphate buffer (pH 5.0). A glycine-sodium hydroxide buffer (0.5 M, pH 10.7) was used to stop the enzyme reaction. On a Lab-CD, sample or standard solution (15 μL), substrate solution (5 μL) and stop solution (5 μL) were respectively introduced into the reservoirs A, D and F using a pipette. Urinary samples were prepared by adding NAG to artificial urine as previously described. 18 The composition of the artificial urine used is given in Table 2 . The Lab-CD was operated by centrifugal force to provide the driving force for fluid transport and mixing as given in Table 3 . The mixture of sample and substrate solution was incubated at 37 C for 20 min by placing a silicone rubber heater on the Lab-CD. Because our Lab-CD system is not equipped with a temperature controller, a doughnut-shaped silicone rubber heater (HAKKO, Nagano, Japan) connected to a thermostat controller (TC-2000, AS ONE) was manually placed on the Lab-CD during enzyme incubation. The thermostat controller was set at 43 C to keep the Lab-CD at about 37 C. The reaction terminated in the reservoir G by mixing the reaction solution and the stop solution using centrifugal force. The free 4-MU released by enzymatic hydrolysis was determined by the fluorescence detection. The average fluorescence intensity during the first 20 s was used for the determination.
Results and Discussion
Lab-CD design and centrifugal operations
In the CD microfluidic platform, the centrifugal force provides the pumping pressure. Fluid flow behavior can be controlled by the angular speed of rotation, fluid density, surface tension, and geometry and location of the channels. Based on our previous experience (unpublished), a Lab-CD for NAG assay was designed and the centrifugal method was developed using each buffer solution containing a fluorescent dye, such as fluorescein and rhodamine B. By stepwise increasing the applied centrifugal rotation, we could observed fluid flow behaviors in a metering chamber C and microchannels under a stroboscopic illumination (Disital Stroboscope, DT-311P, NIDEC-SHIMPO, Kyoto, Japan). The sample is introduced through a loading channel and ca. 330 nL of sample in a metering chamber C (the actual depth of the chamber is 164.2 ± 5.8 μm), wherein the first rotation speed is 800 rpm. The next rotation is the important one. While the sample is still held in the metering chamber, synthetic substrate and stop solution are introduced into the E and G reservoirs, respectively. With the final rotation at 3200 rpm, the reaction solution is dropped into the reservoir G, and then mixed with the stop solution to terminate the reaction. Table 3 and Fig. 4 show the consecutive operations and fluid flow behavior. 
NAG assay protocol
As an initial attempt to develop the NAG assay method on the Lab-CD, two commercial fluorescent substrates, 4-MU-GlcNAc and fluorescein mono-β-D-(2-deoxy-2-Nacetyl)-gluco pyranoside (Marker Gene Technologies, Eugene, OR), were investigated. The substrates are required to have no or very weak fluroescence before enzymatic hydrolysis; however, one of the intact substrates, fluorescein substrate, has a fluorescence at 470/520 nm excitation/detection wavelengths. Thus, 4-MU-GlcNAc and UV-fluorescence detection (excitation 
Enzyme reaction was incubated at 37 C by placing a silicone rubber heater on the Lab-CD. wavelength, 365 -370 nm; detection, 420 -500 nm) were selected in this method. The principle of the method is illustrated in Fig. 5 . For the enzyme incubation, a doughnut-shaped silicone rubber heater was manually placed on the Lab-CD. The temperature was measured in advance on the upper surface of the bottom PDMS plate using a surface temperature sensor. Lab-CD displayed a lower temperature than that of the thermostat controller. When the thermostat controller was set at 43 C, the temperature of the PDMS plate reached 36 C within 2 min and was kept around 37 C. It is obvious that a built-in precision temperature controller is required for the improvement of precision and accuracy in enzyme assay. After the enzyme incubation, the reaction terminated in the reservoir G by mixing the reaction solution and the stop solution using centrifugal force. The free 4-MU released by enzymatic hydrolysis was determined by the fluorescence detection.
Linearity and repeatability
Lab-CD enzyme assay requires precise metering and dilution, adequate microfluidic operations and quantitative detection on the Lab-CD. In order to verify the developed Lab-CD processes, we used standard solutions at the concentration between 0.29 and 2.91 nM of 4-MU in place of a sample. In the preliminary experiment, a linear calibration curve (y = 10.522x -0.62155, r = 0.995) was obtained at this range; hence, the method was applied to the analysis of NAG in urine. Figure 6 shows the results of good linearity (y = 1.6152x + 0.1091, r = 1.000) in a five-concentration assay (2.5 to 20 U L -1 ) for NAG in the artificial urine sample. The repeatability of the method was investigated by analyzing nine samples at the concentration of 7.5 U L -1 and three blanks (artificial urine samples). Due to fluid leakage that occurred during a centrifugal process, one out of twelve determinations failed to detect the released 4-MU. The relative standard deviations for the fluorescence intensity of eight samples and three blanks were 6.4 and 1.9%, respectively. The above linearity and repeatability values were obtained by each operation in a single Lab-CD. Because silicone rubber heater was manually placed on the Lab-CD, the activity of enzymes was affected by changes in the temperature. Furthermore, it is difficult to precisely control the thickness and uniformity of PDMS layers in our laboratory.
Further improvements in both the fast and accurate temperature control and the Lab-CD production are essential to ensure the evaluation of day-to-day and chip-to-chip reproducibility.
Conclusions
A centrifugal Lab-CD platform was developed for urinary enzyme assay. Lab-CD design, centrifugal operations and analytical procedures for NAG assay were established in this work. Automated liquid handling on Lab-CD processes, such as fluid transport, sample metering, mixing, and fluorescence detection are accomplished using a portable Lab-CD system. The linearity of the assay was found to be acceptable in the range of 2.5 to 20 U L -1 . The urinary NAG values were often normalized to the urinary creatinine concentration. This Lab-CD platform may provide a highly promising approach, not only for the integration of analytical processes but also for the simultaneous analysis of multiple analytical targets. 
